Reduction in Resource Utilization
Peritoneal Dialysis (PD) at home
is both more convenient and
less costly than hemodialysis,
which requires 3, 4-hours visits
per week to the dialysis facility.
- The RPM technology is a two-way
connectivity platform that records treatment
information and electronically transfers it
daily through a secure online portal for
a timely review by clinicians.
- The technology also allows clinicians to
change programs remotely.
Conduct a simulated study to estimate
the potential impact of RPM on APD
patients’ use of healthcare resource and
costs in the US, Germany and Italy.
Overview of Study
Tasks (By Whom)
- Development of patient profiles without RPM & with RPM (Nephrologists & PD Nurses)
- Estimation of resources avoided with RPM
- Validation of without RPM scenarios and resources use (Nephrologists expert in APD patient management [USA: 4, Germany: 2, Italy: 1])
- Estimation of resources with RPM (Teams of 1 Nephrologist & 1 PD Nurse experienced in APD patient management [USA: 7, Germany: 3, Italy: 1])
- Computation of difference without RPM / with RPM (Data Management Team)
- Validation of resource avoided estimation (Teams of 1 Nephrologist & 1 PD Nurse experienced in APD patient management with RPM [UK: 2])
in Resource Utilization
across the three countries ranged from
2-5 Emergency Room Visits
1-4 Home Visits
4-8 Unplanned Clinic Visits
Cost Savings per year
across the three countries
In a simulated environment, RPM reduced healthcare system resource utilization and cost in APD patients with problems such as treatment adherence, fluid overload, volume depletion and low drain/unidentified alerts.
This study was conducted in a simulated environment which will require additional studies to confirm findings. Information derived from this study may not correlate with clinical outcomes
Makhija, D.et al. Remote Monitoring of Automated Peritoneal Dialysis Patients: Assessing Clinical and Economic Value. Telemedicine and e-Health, Vol. 24, No. 4, April 2018.
D. Makhija, J. Danek, T. Kudelka, and M. Gellens are employees of Baxter Healthcare Corporation. S. Laplante and J. Sloand were employees of Baxter Healthcare Corporation at the time of the study. K. McLeod is a consultant at Xcenda, funded by Baxter Healthcare Corporation to conduct the study. For all other authors, no competing financial interests exist.